COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 88 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q4 2016. The put-call ratio across all filers is 3.02 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $913,000 | -7.9% | 58,611 | +13.9% | 0.00% | 0.0% |
| Q3 2016 | $991,000 | +62.2% | 51,471 | -0.1% | 0.00% | 0.0% |
| Q2 2016 | $611,000 | +28.6% | 51,546 | +97.1% | 0.00% | 0.0% |
| Q1 2016 | $475,000 | -29.5% | 26,158 | +6.8% | 0.00% | 0.0% |
| Q4 2015 | $674,000 | +21.4% | 24,498 | -2.3% | 0.00% | 0.0% |
| Q3 2015 | $555,000 | +22.0% | 25,085 | -1.5% | 0.00% | 0.0% |
| Q2 2015 | $455,000 | – | 25,479 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rubric Capital Management LP | 1,926,283 | $40,105,000 | 3.74% |
| Camber Capital Management LP | 4,000,000 | $83,280,000 | 2.20% |
| FRAZIER MANAGEMENT LLC | 943,666 | $19,647,000 | 1.76% |
| MANGROVE PARTNERS IM, LLC | 593,741 | $12,362,000 | 1.56% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 303,685 | $6,323,000 | 1.07% |
| Eventide Asset Management | 2,427,976 | $50,550,000 | 0.99% |
| Avidity Partners Management LP | 1,000,400 | $20,828,000 | 0.97% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,108,219 | $23,073,000 | 0.93% |
| Perceptive Advisors | 2,058,068 | $42,849,000 | 0.63% |
| Rock Springs Capital Management LP | 1,175,000 | $24,464,000 | 0.62% |